当前位置: 首页 >> 检索结果
共有 132541 条符合本次的查询结果, 用时 8.1494773 秒

1241. UK PrEP decision re-ignites HIV activism.

作者: The Lancet.
来源: Lancet. 2016年387卷10027期1484页

1242. Bangladesh's rural water scandal.

作者: The Lancet.
来源: Lancet. 2016年387卷10027期1484页

1243. Beat diabetes: an urgent call for global action.

作者: The Lancet.
来源: Lancet. 2016年387卷10027期1483页

1245. Guillain-Barré syndrome associated with Zika virus infection.

作者: Patrícia Brasil.;Patricia Carvalho Sequeira.;Andrea D'Avila Freitas.;Heruza Einsfeld Zogbi.;Guilherme Amaral Calvet.;Rogerio Valls de Souza.;André Machado Siqueira.;Marcos Cesar Lima de Mendonca.;Rita Maria Ribeiro Nogueira.;Ana Maria Bispo de Filippis.;Tom Solomon.
来源: Lancet. 2016年387卷10026期1482页

1246. Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants.

作者: .
来源: Lancet. 2016年387卷10026期1377-1396页
Underweight and severe and morbid obesity are associated with highly elevated risks of adverse health outcomes. We estimated trends in mean body-mass index (BMI), which characterises its population distribution, and in the prevalences of a complete set of BMI categories for adults in all countries.

1247. CNS infection safety signal of RTS,S/AS01 and possible association with rabies vaccine.

作者: Bradford D Gessner.;David C Wraith.;Adam Finn.
来源: Lancet. 2016年387卷10026期1376页

1249. Health equity for LGBTQ people through education.

作者: Robbert J Duvivier.;Elizabeth Wiley.
来源: Lancet. 2016年387卷10026期1375页

1250. Tobacco control in China: still a long way to go.

作者: Shuangshuang Li.;Chuanwei Ma.;Bo Xi.
来源: Lancet. 2016年387卷10026期1375-1376页

1251. A step forward for data protection and biomedical research.

作者: Edward S Dove.;Beth Thompson.;Bartha M Knoppers.
来源: Lancet. 2016年387卷10026期1374-1375页

1252. PATHWAY-2: spironolactone for resistant hypertension - Authors' reply.

作者: Bryan Williams.;Tom M MacDonald.;Steven V Morant.;Morris J Brown.
来源: Lancet. 2016年387卷10026期1373-1374页

1253. PATHWAY-2: spironolactone for resistant hypertension.

作者: Aaron Dale.;Philip Hartley.;Ben Goldacre.; .
来源: Lancet. 2016年387卷10026期1372-1373页

1254. PATHWAY-2: spironolactone for resistant hypertension.

作者: Eugenia Gkaliagkousi.;Eleni Gavriilaki.;Areti Triantafyllou.;Stella Douma.
来源: Lancet. 2016年387卷10026期1372页

1255. A call to reprioritise metrics to evaluate illicit drug policy.

作者: Dan Werb.;Michel Kazatchkine.;Thomas Kerr.;David Nutt.;Steffanie Strathdee.;Catherine Hankins.;Kanna Hayashi.;Julio Montaner.;Don Des Jarlais.;Nazlee Maghsoudi.;Evan Wood.
来源: Lancet. 2016年387卷10026期1371页

1256. PATHWAY-2: spironolactone for resistant hypertension.

作者: Chrysoula Boutari.;Konstantinos Stavropoulos.;Konstantinos Imprialos.;Micheal Doumas.;Asterios Karagiannis.
来源: Lancet. 2016年387卷10026期1371-1372页

1257. John Kurtzke.

作者: Alison Snyder.
来源: Lancet. 2016年387卷10026期1370页

1258. My mother's tongue.

作者: Jemma Benson.
来源: Lancet. 2016年387卷10026期1368-9页

1259. Kazuo Ishiguro's uncanny science.

作者: Daniel Marchalik.;Ann Jurecic.
来源: Lancet. 2016年387卷10026期1365页

1260. Stronger rules needed for medical device cybersecurity.

作者: Brian Owens.
来源: Lancet. 2016年387卷10026期1364页
共有 132541 条符合本次的查询结果, 用时 8.1494773 秒